Trifecta Aortic Bioprosthesis: Midterm Results in 1,953 Patients from a Single Center.

CONCLUSIONS: This is the largest series reporting on outcomes of the Trifecta valve. Our results demonstrate that this valve can be safely implanted in the aortic position with excellent midterm durability and hemodynamics. PMID: 30513317 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30513317?dopt=Abstract

Source: The Annals of Thoracic Surgery - December 1, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Kilic A, Sultan I, Navid F, Aranda-Michel E, Chu D, Thoma F, Gleason TG Tags: Ann Thorac Surg Source Type: research

More News: Cardiovascular & Thoracic Surgery | Coronary Artery Bypass Graft | Heart Valve Surgery | Science | Study